MET Platform Nose-to-Brain Delivery Serves as Foundation for Multiple Virpax Drug Candidates BERWYN, Pa. (BUSINESS WIRE) #pharma Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress dis.